Posterior cortical atrophy and logopenic variant primary progressive aphasia are more specific for Alzheimer’s disease pathology than probable Alzheimer’s disease

Clicks: 7
ID: 324273
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #27 of 113 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Accurately diagnosing Alzheimer’s disease (AD) is challenging, as 15-30% of individuals diagnosed clinically lack evidence of Alzheimer’s disease neuropathological changes (ADNC) at autopsy. While the typical amnestic presentation of Alzheimer’s disease may have limited specificity due to coexisting age-related pathologies, atypical presentations such as logopenic variant primary progressive aphasia (lvPPA) or posterior cortical atrophy (PCA) are often associated with ADNC. This study evaluated how well clinical diagnoses of amnestic and atypical Alzheimer’s disease predict ADNC, and how co-pathologies contribute to clinical-pathological discordance. To evaluate how clinical diagnosis predicts ADNC, we calculated positive predictive values (PPV) and negative predictive values (NPV) for clinical diagnoses of PCA, lvPPA, amnestic Alzheimer’s disease, or non-Alzheimer’s disease dementia for ADNC, using four neuropathological thresholds defined by combinations of the Consortium to Establish a Registry for Alzheimer’s disease (CERAD) neuritic plaque frequency (moderate or frequent) and Braak stage (III–VI or V–VI). Analyses were replicated in vivo using amyloid- and tau-PET positivity (A+T+) as a surrogate for Alzheimer’s disease pathology. We also quantified the frequency of co-pathologies and assessed their contribution to false-positive Alzheimer’s disease diagnoses. This study included 6363 autopsy-confirmed cases from the National Alzheimer’s Coordinating Center (NACC) database (mean age: 80.0±11.4 years; 46.0% female) and 76 participants from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort (mean age: 67.9±9.94 years; 55.3% female). The PPV of probable Alzheimer’s disease dementia ranged from 58–80%, while PCA and lvPPA showed higher PPVs (81–96% and 80–92%, respectively) for ADNC. The NPV of probable Alzheimer’s disease dementia ranged from 66–83%, compared with 38–58% for PCA and lvPPA. In TRIAD, individuals with PCA or lvPPA had 100% PPV for Alzheimer’s disease biomarker abnormality, whereas amnestic Alzheimer’s disease dementia showed a PPV of 78.1%. Among Alzheimer’s disease dementia cases, 20.2% were ADNC-negative, with a higher frequency of false-positive diagnoses in late-onset compared with early-onset cases (23.8% vs. 6.9%). Among ADNC-negative Alzheimer’s disease dementia cases, vascular pathology was the most common pathology (early-onset: 93%; late-onset: 98%). In the late-onset group, limbic-predominant age-related TDP-43 encephalopathy occurred in 31% of the cases, followed by Lewy body pathology (28.8%) and primary age-related tauopathy (24.3%). Visuospatial and language variants of clinical Alzheimer’s disease offer excellent predictive value for underlying Alzheimer’s disease pathology, both in vivo and at autopsy, outperforming the amnestic presentation classically associated with Alzheimer’s disease. Clinical-pathological discordance in amnestic Alzheimer’s disease dementia is frequently associated with coexisting age-related and vascular pathologies, highlighting the complexity of interpreting clinical Alzheimer’s disease diagnoses in the absence of ADNC.
Reference Key
openalex_W7196964576 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lydia Trudel, Joseph Therriault, Arthur C Macedo, Nesrine Rahmouni, Jean‐Paul Soucy, Serge Gauthier, Paolo Vitali, Marie-Christine Guiot, Lili‐Naz Hazrati, Pedro Rosa‐Neto
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag304
URL
https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcag304/70511650/fcag304.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.